" class="no-js "lang="en-US"> Jingsong Wang - Medtech Alert
Saturday, August 23, 2025
Jingsong Wang

Jingsong Wang

About Jingsong Wang

Mr. Jingsong Wang, M.D., Ph.D., is our principal Founder, Chairman and chief executive officer. Prior to founding our company, Dr. Wang served as head of China R&D and head of translational medicine, Asia Pacific, at Sanofi. He is a former attending physician and clinical fellow at Harvard Medical School. Dr. Wang received his Ph.D. in Molecular Pharmacology from China Pharmaceutical University and has also completed a Molecular Immunology Research Fellowship at Dr. Laurie Glimcher’s laboratory at the Harvard School of Public Health.

Related Story

Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer

April 14 2022

Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), today announced the appointment of Dr. Humphrey Gardner as Chief […]

Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment

June 16 2021

Harbour BioMed (HKEX: 02142) announced today it has entered into a multi-year, multifaceted research collaboration […]